Relapses in MS Patients Using Gilenya May Be Result of Changes Within T-Cells, Study Reports
…
More to know of OCREVUS (Ocrelizumab),
…
Stuart Schlossman
RedHill BioPharma Awaits Patent for RHB-104, Potential MS Treatment, from Japan
…
Stuart Schlossman
MS Medications – Who is using what?
…
Stuart Schlossman
CMSC INforMS: Tysabri May Be More Effective Than Gilenya at Reducing Disease Activity in MS Patients
…
Stuart Schlossman
How Tecfidera Works to Reduce MS Relapses Discovered, May Lead to Better Treatments
…
Stuart Schlossman
10 Reasons You Should Start Treating Your MS
…
Stuart Schlossman
Will Tclena Become A Big Player In Multiple Sclerosis?
…
Stuart Schlossman
NICE Planning to Reject MS Treatment, Zinbryta, in England and Wales
…
Stuart Schlossman
Phase 3 Study to Test Oral Combination, Tecfidera and Ponesimod, to Treat Relapsing MS
…
Stuart Schlossman
